1 |
Wu Y, Li X, Li Q, Cheng C, Zheng L. Adipose tissue-to-breast cancer crosstalk: Comprehensive insights. Biochim Biophys Acta Rev Cancer 2022;1877:188800. [PMID: 36103907 DOI: 10.1016/j.bbcan.2022.188800] [Reference Citation Analysis]
|
2 |
Saponaro C, Fanizzi A, Sonnessa M, Mondelli P, Vergara D, Loisi D, Massafra R, Latorre A, Zito FA, Schirosi L. Downstream Signaling of Inflammasome Pathway Affects Patients’ Outcome in the Context of Distinct Molecular Breast Cancer Subtypes. Pharmaceuticals 2022;15:651. [DOI: 10.3390/ph15060651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Liu C, Huang X, Su H. The role of the inflammasome and its related pathways in ovarian cancer. Clin Transl Oncol 2022. [PMID: 35288840 DOI: 10.1007/s12094-022-02805-y] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
4 |
Wang F, Li J, Li L, Chen Z, Wang N, Zhu M, Mi H, Xiong Y, Guo G, Gu Y. Circular RNA circ_IRAK3 contributes to tumor growth through upregulating KIF2A via adsorbing miR-603 in breast cancer. Cancer Cell Int 2022;22:81. [PMID: 35164763 DOI: 10.1186/s12935-022-02497-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|